Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age

por Moreira, E. D., Giuliano, A. R., de Hoon, J., Iversen, O.-E., Joura, E. A., Restrepo, J., Van Damme, P., Vandermeulen, C., Ellison, M. C., Krick, A., Shields, C., Heiles, B., Luxembourg, A.
Publicado 2017